- Breaking News Japan welcomes reelection of Karzai as Afghan president, vows support
- Breaking News U.S. editorial excerpts -2-
- Breaking News 3RD LD: Blast in Pakistan's Rawalpindi kills at least 30
- Breaking News Obama reaffirms support for Karzai as run-off is cancelled
Anti-heroin drug buprenorphine is best for helping addicts: study
0 Comments | AFP, June, 2008
PARIS (AFP) — The drug buprenorphine is twice as effective as a rival treatment called naltrexone in helping heroin patients stay off the narcotic, a trial published in The Lancet on Friday said.
The two drugs, along with a dummy pill called a placebo, were tested for 22 months among 126 patients in Malaysia who had emerged from a detoxification and counselling programme, it said.
Buprenorphine, which is marketed as Temgesic or Buprenex, was twice as effective as naltrexone (branded as Revia, Depade or Vivitrol) and the placebo in terms of days of abstinence from heroin and a full-fledged relapse to the narcotic.
Indeed, buprenorphine proved to be so superior that the trial was halted early, as it would have been unethical to continue it to its scheduled...
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Empirically assessing the impact of BPR on banking firms
- Kemarie McMinn Named Executive Vice President of Halo Debt Solutions, Inc.
- Halo Debt Solutions, Inc. Supports Push Toward Industry Regulation
- Traction Named #1 Interactive Agency for 2009 by BtoB Magazine
- Halo Debt Solutions, Inc. Gives Debt Settlement a Face-Lift
- Banking technology, technological learning and competition: comparative case studies in Thai banking